Central Serous Chorioretinopathy (CSC) Completed Phase 2 Trials for Eplerenone (DB00700)

Also known as: Central Serous Chorioretinopathy / Central Serous Retinopathy (CSR) / Central Serous Retinopathy / Serous macular detachment

IndicationStatusPhase
DBCOND0050251 (Central Serous Chorioretinopathy (CSC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01822561Eplerenone for Central Serous ChorioretinopathyTreatment